Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana s Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings.
India is close to finishing an investigation into a complaint that a state drug regulator helped switch samples of cough syrups linked to the deaths of children in Gambia before they were tested in India. The World Health Organization (WHO) linked the syrups made by India s Maiden Pharmaceuticals to the deaths of 70 children in the African country last year. India s government says tests at an Indian government laboratory showed the syrups were not toxic.